NEW CONCEPTS IN TRANSLATIONAL CARDIAC RESEARCH |
Lost in
Translation: Issues in Translating Basic Research to Clinical
Practice
Peter M.
Buttrick,
University of Colorado, Denver, U.S.A. |
Structural Biological
Approach to Cardiovascular Diseases
Hidezo Mori,
National Cardiovascular Center Research Institute,
Osaka Japan
|
Parallels between
the Neurodegenerative and Cardiovascular Diseases
Jeffrey Robbins,
Children's Hospital Research Foundation,
Cincinnati,
OH,
U.S.A.
|
Lipoprotein
Autoimmunity as a Novel Target for Treatment of Cardiovascular Disease
Jan Nilsson,
University Hospital MAS, Malmo, Sweden
|
Role of NO in the
Control of Mitochondrial Function in Cardiovascular Disease
Thomas H. Hintze,
New York
Medical College, Valhalla, NY, U.S.A.
|
Evidence-Based
Alternative and Complementary Therapies for CVD
Maura
Paul-Labrador,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
|
Selective Nuclear
Receptor Modulation in Cardiometabolic Disease
Ulrich Kintscher,
Universitatsmedizin Berlin, Berlin, Germany
|
Endogenous Secretory
Rage: A Potential
Target
for Cardiovascular Diseases and Metabolic Syndrome
Hidenori Koyama,
Osaka City University Graduate School of Medicine, Osaka, Japan
|
Subtype-Specific
b-Adrenergic
Receptor Signaling In the Heart
Rui-Ping Xiao,
National Institute on Aging, NIH, Baltimore, MD, U.S.A.
|
Different Signaling
Pathways in Cardiomyopathy Resulting from Chronically Enhanced
Beta-Adrenergic Receptive Signaling
Stephen F. Vatner,
New Jersey Medical School, Newark, NJ, U.S.A.
|
ENDOTHELIAL BIOMEDICINE: NEW OPPORTUNITIES FOR DIAGNOSIS AND
TREATMENT |
The Biology of
Endothelial Progenitor Cells
Hyo-Soo Kim,
Seoul
National University Hospital, Seoul, Korea
|
Vascular Progenitor
Cells - Putative Role in Atherosclerosis
Noel M.
Caplice,
Mayo Clinic, Rochester, MN, U.S.A.
|
Endothelial
Dysfunction in Ischemic Heart Disease: Ready for the Clinician
Use?
Pasquale
Perrone-Filardi,
Fererico II University, Naples, Italy |
Endothelial
Biomedicine and Cardiovascular Health: Unique Opportunities for the 21st
Century
George A.
Mensah,
Center for Disease Control and Prevention, Atlanta, GA, U.S.A.
|
Coronary Endothelial
Dysfunction in Left Ventricular Hypertrophy: Mechanisms and Treatment
Louis P. Perrault,
Montreal Heart Institute, Montreal, Quebec, Canada |
Flow-Mediated
Dilation and Arterial Stiffness: Are Really Useful Clinical Indices?
Spyridon
Koulouris,
Evangelismos Hospital, Athens, Greece |
Diabetes and
Arteriosclerosis - The Role of Endothelial Dysfunction
Nikolaus
Marx,
University of Ulm, Germany |
OXIDATIVE STRESS AND ANTI-OXIDANT THERAPY |
Nitric Oxide /
Nitroxidative Stress Imbalance in the Failing Heart - Nanomedical
Approach
Tadeusz Malinski,
Ohio University, Athens, OH, U.S.A.
|
Reactive Oxygen
Species and Neovascularization
Masuko Ushio-Fukai, University
of Illinois at Chicago,
Chicago, IL, U.S.A.
|
Oxidative Stress,
Antioxidants and Atherosclerosis
Shing-Jong
Lin,
Taipei Veterans General Hospital, Taipei, Taiwan
|
Hifs: New Players in
Vascular Redox Signaling
Agnes
Gorlach,
German Heart Center Munich at the TU Munich, Germany
|
Vascular Oxidative
Stress: Relative Importance of Pro- and Antioxidant Enzyme Systems
Ulrich Forstermann,
Johannes Gutenberg University, Mainz, Germany
|
Oxidative Stress and
Extracellular Sod in Cardiovascular Disease
Tohru Fukai,
University of Illinois at Chicago, Chicago, IL, U.S.A. |
Decrease in Il-10/Tnf-alpha
Ratio and Increase in Oxidative Stress in Heart Failure
Pawan
K. Singal,
University of Manitoba, Winnipeg, Manitoba, Canada |
Hypoxia Inducible
Factor-1 in the Heart
Ralph V. Shohet,
University of Hawaii, Honolulu, U.S.A.
|
INFLAMMATION AND ATHEROGENESIS: SESSION 1 |
The Role of Crp
in Atherothrombosis
Ishwarlal
Jialal,
UC Davis Medical Center, Sacramento, CA, U.S.A.
|
Does C-Reactive
Protein Orchestrate Inflammation in Acute Coronary Artery Diseases?
Janos G.
Filep,
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
|
Origin of Low-Grade
Systemic Inflammation: Implications for Vascular Diseases
Doron Aronson,
Rambam Medical Center, Haifa, Israel
|
Does C-Reactive
Protein Reflect Inflammation of the Atherosclerotic Plaques in Coronary
Arteries?
Harisios Boudoulas,
Academy of Athens, Greece |
Prostanoids and
Isoprostanoids in Atherogenesis
Domenico
Pratico,
University of Pennsylvania, Philadelphia, PA, U.S.A.
|
The Role of
Antigen-Presenting Cells in Cardiovascular Disease: a Potential
Therapeutic Target?
Alexander
Niessner,
Medical University of Vienna, Austria
|
Diet vs. Infection
Atherosclerosis: What Have We Learnt
Salomon Amar,
Boston University School of Dental Medicine, Boston, MA, U.S.A. |
INFLAMMATION AND ATHEROGENESIS: SESSION 2 |
The Inflammatory
Response in the Neonate and Its Management
Timothy
F. Feltes,
Ohio State University, Columbus, Ohio, U.S.A.
|
Immune Response to
OXLDL and its Impact in Atherosclerosis
Xinghua Zhou,
Karolinska Hospital, Stockholm, Sweden
|
The
Anti-Inflammatory and Anti-Atherogenic Effects of Insulin
Paresh
Dandona,
State University of New York at Buffalo, Buffalo, NY, U.S.A.
|
The Interplay of
Dyslipidemia and Inflammation in the Evolution of Atherosclerotic Plaque
Andrea
Mezzetti,
"G. d'Annunzio" University, Chieti, Italy |
GENETIC BASIS OF CARDIOVASCULAR DISEASE |
The Role of Variations in the Innate Immune Response in Viral
Myocarditis
Neil E.
Bowles,
University of Utah School of Medicine, Salt Lake City, UT, USA |
New Insights into
the Genetics of Dilated Cardiomyopathies
Luisa
Mestroni,
University of Colorado Bioscience Park Center, Aurora, CO, USA |
Genetics of
Vasovagal Syncope
Robert S.
Sheldon,
University of Calgary, Alberta, Canada
|
Pursuing Genes that
Contribute to Coronary Artery Disease - An Idea whose Time has Come
Robert
Roberts,
University of Ottawa Heart Institute, ON, Canada
|
Comprehensive
Approaches for Identification of Susceptibility Genes to Myocardial
Infarction
Mitsuhiro
Yokota,
Aichi-Gakuin University, School of Dentistry, Nagoya Japan
|
Clinical Genomic and
Proteomic Approaches to Understand Cardiovascular Disease
Cam
Patterson,
University of North Carolina at Chapel Hill, NC, U.S.A. |
CARDIAC REPAIR AND REGENERATION: SESSION 1 |
Myocardial
Restoration with Stem Cells and Bioartificial Tissues; Pandora's Box on
the Scale
Theo
Kofidis,
National
University Hospital, National University Singapore
|
Stem Cells and
Vascular Diseases
Qingbo
Xu, St.
George's Hospital Medical School, London, England
|
Therapeutic
Angiogenesis Using VEGF-E/Human PLGF Chimeric Genes
Toyoaki Murohara,
Nagoya University Graduate School of Medicine, Nagoya, Japan |
Injectable
Biomaterials for Myocardial Repair
Jonathan
Leor,
Sheba Medical Center, Tel Hashomer, Israel |
Labeling of Stem
Cells for Noninvasive Delivery and Tracking in Cardiovascular
Regenerative Therapy
Dara L. Kraitchman,
Johns Hopkins University, Baltimore, MD, U.S.A. |
Human Cardiomyocyte Progenitor Cells Differentiate into Functional
Cardiomyocytes in Vitro
Pieter A. Doevendans,
University Medical Center Utrecht, The Netherlands |
Skeletal Myoblasts
for Chronic Heart Failure
Peter Smits,
Medical Center Rijnmond Zuid (MCRZ), Rotterdam, The Netherlands
|
CARDIAC REPAIR AND REGENERATION: SESSION 2 |
Progenitor Cells
Mobilization in Acute Myocardial Infarction
Ilka Ott,
Deutsches Herzzentrum, Munchen, Germany
|
Novel Endogenous
Myocardial Repair Strategies for the Treatment of Heart Failure
Y. Joseph Woo,
University of Pennsylvania School of Medicine, Philadelphia, PA, U.S.A.
|
Long-Lasting
Plasticity of Slow-Twitch Skeletal Myoblasts with Connexin-43 for the
Efficient Engraftment and Functional Improvement of Failing Heart
Teruhiko
Toyo-oka,
Tohoku University, Aoba-ku, Sendai, Japan
|
Unlocking the
Mysteries That Govern Vascular Cell Life and Cell Longevity
Kenneth
Maiese,
Wayne State University School of Medicine, Detroit, MI, U.S.A.
|
Therapeutic
Angiogenesis in Ischemic Diseases
Jeran-Sebastien Silvestre,
Hopital Lariboisiere, Paris, France
|
Cell Transplantation
to Improve Heart Function: Myogenesis, Angiogenesis or Matrix Modulation
Ren-Ke Li,
University of Toronto, Ontario, Canada
|
Myocardial
Regeneration
Roger Laham,
BIDMC/Harvard Medical School, Boston, MA, U.S.A.
|
MOLECULAR IMAGING: FILLING THE GAP BETWEEN PATHOPHYSIOLOGY AND
CLINICAL ARENA |
Metabolic
Imaging of the Heart: Beyond Anatomy
Vasken Dilsizian,
University of Maryland School of Medicine, Baltimore, MD, U.S.A.
|
Molecular Imaging in
Atherosclerosis
Masanori
Aikawa,
Brigham & Women's Hospital, Boston, MA, U.S.A.
|
Molecular Imaging in
Cardiovascular Diseases
Elena
Aikawa,
Massachusetts General Hospital, Charlestown, MA, U.S.A.
|
BIOMARKERS TODAY |
Atherosclerosis
Lab Risk Markers Today: Research and Clinical Implications
Wolfgang Koenig,
University of Ulm Medical Center, Germany
|
Biomarkers in
Unstable Coronary Syndromes
Dimitris
Tousoulis,
Hippokration Hospital, Athens, Greece |
NEW CONCEPTS IN STRESS TESTING AND ECHOCARDIOGRAPHY |
Exercise ECG in
the Interventional Era: Out of Date or Evergreen?
Riccardo
Bigi,
University School of Medicine, Milan, Italy
|
Stress Echocardiography and New
Technologies
Rosa Sicari,
CNR Institution of Clinical Physiology,
Pisa,
Italy
|
Value and
Significance of E/E' by Doppler Echocardiography: More than Meets the
Eye?
Cristina
Pislaru,
Mayo Clinic, Rochester, MN, U.S.A.
|
Role of Myocardial
Contrast Echocardiography in Acute Myocardial Infarction
Roxy Senior,
Northwick Park Hospital, Harrow, Middlesex, UK |
Assessing LV
Function by Echocardiography: the Challenge Continues
Fausto
J. Pinto,
University Hospital Sta Maria, Lisbon University, Portugal
|
Three Dimensional
Echocardiography 2007
Folkert J.Ten
Cate,
Thoraxcenter Ba 304, Rotterdam, The Netherlands
|
3D Echocardiography - Clinical Applications and Future
Directions
Smadar
Kort,
Stony Brook University Medical Center, Stony Brook, NY, U.S.A. |
NOVEL
IMAGING TECHNIQUES TO ASSESS CARDIAC PERFUSION, FUNCTION AND
VIABILITY |
Acute Heart Failure:
New Diagnostic and Therapeutical Perspectives
Francesco
Fedele,
Universita Degli Studi Di Roma "la Sapienza", Roma, Italy
|
The Future of Stress
Perfusion Imaging In the Era of CT
Rory
Hachamovitch,
University of Southern California, Los Angeles, CA, U.S.A.
|
Revascularization in
Left Ventricular Systolic Dysfunction: The Role of Viability Testing
Panithaya
Chareonthaitawee,
Mayo Clinic, Rochester, MN, U.S.A. |
MULTISLICE CT IN CLINICAL CARDIOLOGY |
The Emergence of
Cardiovascular CT in Clinical Cardiology
Joao A.C.
Lima,
Johns Hopkins Hospital, Baltimore, MD, U.S.A.
|
Multi-Slice CT- and
Its Role in Clinical Cardiology
Stephen
Schroeder,
Division of Cardiology,
Tuebingen, Germany |
A Comparison between
Coronary Angiogram and Multislice CT in Coronary Artery Disease. A Study
of 150 Cases
Sergio
Dalla-Volta,
Universita degli Studi di Padova, Italy |
Considering Coronary
Artery Calcium
Elizabeth L. Barrett-Connor,
University of California, San Diego, La Jolla. CA, U.S.A.
|
Coronary Artery
Bypass Grafts and CT Angiography
Leonard Kritharides,
Concord Hospital, Concord, Australia |
Is There a
Role for CT Coronary Angiography in Clinical Practice?
Mario
J. Garcia,
Cleveland Clinic Foundation, Cleveland, OH, U.S.A.
|
Atherosclerosis
Imaging: Where are We and Where are We Going?
Sanjay
Rajagopalan,
Mount Sinai School of Medicine, New York, NY, U.S.A.
|
CARDIAC MRI IN CLINICAL CARDIOLOGY |
Noninvasive
Imaging of Atherothrombosis by MRI
Roberto Corti,
University Hospital Zurich, Switzerland |
Assessment of
Atheroma Plaque by Cardiac MR and
Cardiac CT:
Current and Future Clinical Impact
Luis J.
Jimenez-Borreguero,
Hospital Universitario de la Princesa,
Madrid,
Spain
|
Cardiovascular
Magnetic Resonance (CMR) 2007 and Beyond
Gerald Pohost,
USC School of Medicine, Los Angeles, U.S.A.
|
Magnetic Resonance
Imaging Characterization of Advanced Atherosclerotic Plaques
Chun
Yuan,
University of Washington, Seattle, WA, U.S.A.
|
PATHOGENESIS OF ATHEROSCLEROSIS |
Tissue Factor
and Cardiovascular Disease
Felix C.
Tanner,
University of Zurich, Switzerland
|
Role of Lox-1 in Atherosclerosis; Lessons from Knockout Mice
Jawahar L.
Mehta,
University of Arkansas for Medical Sciences, Little Rock, AR, U.S.A.
|
Mast
Cells Promote Atherosclerosis
by Releasing Pro-Inflammatory Cytokines
Guo-Ping
Shi,
Brigham and Women's Hospital, Boston, MA, U.S.A. |
Vessel Aging
and the Development of Atherothrombosis
Paul
Holvoet,
The Center for Experimental Surgery and Anesthesiology, Leuven,
Belgium |
Cholesteryl
Esters From ACAT2 are Atherogenic in Mice and Monkeys
Lawrence L. Rudel,
Wake Forest University School of Medicine, Winston-Salem, NC,
U.S.A. |
Atherosclerotic Plaque Development at the Strain / Stress
Interface
Stephanie Lehoux,
INSERM CRC Lariboisiere, Paris,France |
THE VULNERABLE PLAQUE AND ACUTE CORONARY SYNDROMES |
A Role of Coronary Angioscopy for the Detection of Vulnerable
Plaques and Vulnerable Patients
Yasunori
Ueda,
Osaka Police Hospital, Osaka, Japan |
Thrombus Age in
Acute Coronary Syndromes: A Tale of the Old and the New
Robert J.
de Winter, Academic Medical Center, Amsterdam, The Netherlands |
New Approaches to
Vulnerable Plaque Detection
Robert L.
Wilensky,
Hospital of the University of Pennsylvania, Philadelphia, PA, U.S.A. |
Imaging of the
Vulnerable Plaque: Indications, Challenges and Future Directions
S. David
Gertz, St. Luke's Episcopal Hospital,
Houston, TX, U.S.A. |
CARDIOPROTECTIVE MECHANISMS IN MYOCARDIAL ISCHEMIA |
Cytoprotective
and Cardioprotective Effects Of Hydrogen Sulfide
Csaba
Szabo,
Ikaria Inc., Seattle, WA, U.S.A. |
DNAZYMES in the
Treatment of Cardiovascular Disease
Harry Lowe,
University of Sydney, Australia
|
Peptide-Induced
Cardioprotection - Insights into Novel Mechanisms
Cherry L.
Wainwright,
The Robert Gordon University, Aberdeen, United Kingdom |
Role of Protein
Kinase C in Reperfusion Arrhythmias
Mohamed
Boutjdir,
NY Harbor Healthcare System, Brooklyn, NY, U.S.A. |
Insulin-Triggered
Cell Survival Signaling and its Protection against Myocardial Ischemia /
Reperfusion Injury
Feng Gao,
Fourth Military Medical University, Xi'an, China |
Limiting Myocardial
Ischemia-Reperfusion Injury: Preconditioning, Postconditioning and
Beyond
Karin
Przyklenk,
University of Massachusetts Medical School, Worcester, MA, U.S.A. |
Ischemic Pre- and
Post-Conditioning: Clinically relevant or not?
Warren K.
Laskey,
University of New Mexico School of Medicine, Albuquerque, NM, U.S.A. |
INSIGHTS INTO THE TREATMENT OF ACUTE CORONARY SYNDROMES |
Management and
Outcome of Elderly with ACS
Shmuel
Gottlieb,
Bikur Cholim Hospital, Jerusalem, Israel |
Laser Thrombolysis
in Acute Ischemic Thrombotic Syndrmoes - The Impact of Technique on
Clinical Outcome
On Topaz,
McGuire VA Medical Center, Richmond, VA, U.S.A. |
Role of ABCIXIMAB in
Primary Stenting for Acute Myocardial Infarction
David L.
Brown,
State University of New York, Stony Brook, NY, U.S.A. |
Prognostic
Importance of Bleeding in ACS
John W.
Eikelboom,
McMaster University, Hamilton, ON, Canada |
New Insights Into
The Benefits Of Antiplatelet Therapy In Patients With CAD
Nasser M.
Lakkis,
Ben Taub General Hospital, Baylor College of Medicine, Houston, TX,
U.S.A. |
Facilitated PCI for
Acute MI: The Role of Anti-GP IIB/IIIA
Leonardo
Bolognese,
Azienda Ospedaliera Arezzo, Arezzo, Italy
|
NEW
DIRECTIONS IN CORONARY INTERVENTIONAL THERAPY |
Renal Disease
Impact on Coronary Interventional Outcomes
George W.
Vetrovec,
Virginia
Commonwealth University, Richmond, VA, U.S.A. |
Development of a
Novel Bioabsorbable Polymeric Nanoparticle-Eluting Stent by an
Actively-Controlled Multilayer Coating Technology
Kensuke
Egashira,
Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan |
Left Main Stenting:
Are we there yet?
Fayaz Shawl,
Washington Adventist Hospital, Takoma Park, MD, U.S.A. |
Percutaneous
Interventional Treatment of Left Main Stenosis. A Critical Appraisal
Harald Mudra,
Krankenhaus Munchen Neuperlach, Munchen, Germany |
THE
ERA OF DRUG ELUTING STENTS: LIGHTS AND SHADES |
Cost-Effectiveness
of Drug-Eluting Stents
Mark J.
Eisenberg,
The Jewish General Hospital, Montreal, Quebec, Canada |
The Use of Drug
Eluting Stents in Complex Coronary Lesions Anno 2007
Henning
Kelbaek,
Rigshospitalet & Skejby Hospital, Denmark |
Treatment of in-Stent
Restenosis with Drug-Eluting Stents - Insights from Intravascular
Ultrasound Findings
Thomas M.
Schielem,
Universitat Munchen-Innenstadt, Munich, Germany |
Coronary Stent
Thrombosis in The Era of Drug-Eluting Stents
Raul
Moreno,
University Hospital La Paz, Madrid, Spain |
Drug-Eluting Stents:
Is the Increased Risk of Stent Thrombosis an Acceptable Clinical
Tradeoff for Reduced Restenosis?
Sanjay Kaul,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
Anti-Platelet
Therapy in Drug-Eluting Stent Era
Myung Ho
Jeong,
National University Hospital Dong-gu, Gwangju , Korea |
Is Long –Term Safety the “Achilles Heel” of Drug-Eluting Stents
Barry F.
Uretsky,
University of Texas Medical Branch at Galveston, TX, U.S.A. |
ADVANCES IN STRUCTURAL INTERVENTIONS |
Indications for
Percutaneous Closure of PFOs
Eric
Rosenthal,
Guy's Hospital, London, England |
Application of
Angioscopy for Diagnosis and Treatment of Venous Thromboembolism
Takanobu
Tomaru,
Toho University Sakura Hospital, Japan
|
TREATMENT OF CAROTID STENOSIS - STATE-OF-THE-ART |
Carotid
Angioplasty under Protection. Limitations. New Developments
Michel
Henry,
Nancy, France |
Embolic
Protection during Carotid Stenting with the New Fibernet Device
Horst
Sievert,
Cardiovascular Center Frankfurt, Germany
|
Carotid Artery
Disease: Stent versus Scalpel!
Satyendra
Giri,
Baystate Medical Education & Research Foundation,
Springfield,
MA,
U.S.A. |
NEW TREATMENTS OF PERIPHERAL ARTERIAL DISEASE |
New Insights
into Peripheral Arterial Disease
Michael
H. Criqui,
University of California San Diego, La Jolla,
CA,
U.S.A. |
Endovascular
Treatment of Peripheral Arterial Diseases
Debabrata
D. Mukherjee,
University of Kentucky, Lexington, KY, U.S.A. |
The Changing
Paradigm of Renal Artery Stenosis
George A.
Stouffer,
University of North
Carolina, Chapel Hill, NC, U.S.A. |
Inter-Relationship
of Coronary Artery Disease and Peripheral Arterial Disease
Verghese
Mathew,
Mayo Clinic, Rochester, MN, U.S.A. |
EVOLVING TREATMENT STRATEGIES FOR ISCHEMIC CORONARY DISEASE |
Treatment of
Stable Angina: What works and What is New?
Udho
Thadani,
University of Oklahoma HSC, Oklahoma City, OK, U.S.A. |
ACE2: Potential
Target for CV Therapeutics
Mohan K.
Raizada,
University of Florida, Gainesville, FL, U.S.A. |
Advances in
Pharmacotherapy Of Angina
Kanu
Chatterjee,
UCSF School of Medicine, San Francisco, CA,
U.S.A. |
Bleeding and Blood
Transfusion Issues in Patients with Ischemic Heart Disease
Sunil V Rao,
Durham VA Medical Center, NC, U.S.A. |
Angina: Effective
Therapy or a Waste of Time?
Greg Barsness,
Mayo Clinic, Rochester, MN, U.S.A |
Opportunities with
Integrin-Targeted Perfluorcarbon Nanoparticles in Atherosclerosis
Gregory M.
Lanza,
Washington University, St Louis, MO, U.S.A. |
Coronary Artery
Bypass Grafting for Stenotic Lesiosn caused by Kawasaki Disease
Etsuko Tsuda,
National Cardiovascular Center, Osaka, Japan |
EPIDEMIOLOGY OF HEART DISEASE |
CHD and South Asians
- The Current Epidemic
Sandeep Gupta,
Whipps Cross and St. Bartholomew's Hospitals,
Leytonstone,
UK
|
Heart Disease in
Africa: Is there an Epidemiological Transition?
Patrick J.
Commerford,
Groote Schuur Hospital, Cape Town, South Africa |
Clinical Profile and
Genetic Basis of Brugada Syndrome in the Chinese Population
Ngai-Shing
Mok, Lai
Chi Kok, Kowloon, Hong Kong, China |
Measuring the
Quality of Heart Failure Care
Paul A.
Heidenreich,
Palo Alto VA Health Care System, Palo Alto, CA, U.S.A. |
Coronary Artery
Disease in Asian Indians
Narendra C.
Bhalodkar,
Bronx-Lebanon Hospital Center, Bronx, NY, U.S.A. |
CARDIOVASCULAR RISK ASSESSMENT |
Why do Men Have More Heart Disease than Women?
Kevin S.
Channer,
Royal Hallamshire Hospital, Sheffield, England |
Migraine and Risk of
CVD
Tobias Kurth,
Brigham and Women's Hospital, Boston, MA, U.S.A. |
The Role of Aspirin
Resistance in the Setting of Coronary Artery Disease
Michael N.
Zairis,
Piraeus, Greece
|
Aspirin Resistance:
Fact or Fallacy?
Lewis C.
Becker,
Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A. |
Mediterranean Diet
and Coronary Heart Disease,
is Obesity a Link?
Demosthenes
B. Panagiotakos,
Harokopio University,
Athens,
Greece |
Biomarkers of
Cardiovascular Risk, Race / Ethnicity and Gender
Michelle A.
Albert,
Brigham and Women's Hospital, "Boston,
MA, U.S.A. |
Personalized
Prognosis for Decision-Making: Actualizing the Framingham Dream in the
21st Century
Eugene M.
Blackstone,
The Cleveland Clinic, OH, U.S.A. |
Metabolic Syndrome,
Subclinical Atherosclerosis, and Cardiovascular Risk
Nathan D.
Wong,
University of California, Irvine, CA, U.S.A. |
LIPOPROTEINS AND CARDIOVASCULAR DISEASE |
Aggressive Lipid Management: LDL Apheresis
Donna Polk,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
HDL Therapy, Oral
APOA-1 Mimetic Peptides
Mohamad Navab,
David Geffen School of Medicine at UCLA, Los Angeles, CA, U.S.A. |
Increasing HDL: How
a 'Garbage' Truck Turned Into a Vessel-Repair Unit
Erik S.G.
Stroes,
Academic Medical Center, University of Amsterdam, The Netherlands |
Lipid Storage in
Cells; Mechanism and Implications for Cardiovascular Diseases
Sven-Olof,
Olofsson Sahlgrenska University Hospital, Goteborg, Sweden |
NOVEL
CONCEPTS IN SYSTEMIC AND PULMONARY HYPERTENSION |
How low is too low?
Is there a Limit to Blood Pressure Lowering?
Clive
Rosendorff,
VA Medical Center, Bronx, NY, U.S.A. |
A Vascular
Apoptosis-Based Theory for Pulmonary Arterial Hypertension and a
Framework for the Development and Translation of Novel
Experimental Therapies
Evangelos Michelakis,
University of Alberta, Edmonton, Canada |
Clinical Guidelines
for the Primary Prevention of Hypertension: Can we do more?
Howard Sesso,
Brigham and Women's Hospital, Boston, MA, U.S.A. |
Chronotherapy in
Hypertension: Impact on Cardiovascular Risk Reduction
Ramon C.
Hermida,
E.T.S.I. Telecomunicacion, Vigo (Pontevedra), Spain |
Vascular Signaling
in Hypertension - Current Concepts and Future Directions
Rhian M.
Touyz,
University of Ottawa, ON, Canada |
From Hypertension to
Heart Failure: Can We Interrupt the Course
Vasilios
Papademetriou,
Georgetown University, Washington, DC, U.S.A. |
Human
Immunodeficiency Virus-Associated Pulmonary Hypertension: Pathogenesis
and Clinical Aspects
Giuseppe
Barbaro,
University of Rome ""La Sapienza" Rome,
Italy
|
Cardiac Biomarkers
in Pulmonary Embolism and Pulmonary Hypertension
Ijaz A. Khan,
University of Maryland School of Medicine, Baltimore, MD, U.S.A. |
THE
METABOLIC SYNDROME: EMERGING EPIDEMIC OF THE CENTURY? |
Developmental
Programming of Cardiovascular Control by Maternal Nutrition: Influence
of Adolescent Obesity
David S.
Gardner,
University of Cambridge, England |
Targeting
Lipoprotein Subclass Abnormalities in the Metabolic Syndrome: New
Opportunities for Cardiovascular Risk Reduction
Robert S.
Rosenson,
Northwestern University, Chicago, IL, U.S.A. |
Metabolic Syndrome
in Early Life and its Consequences
Gerald S.
Berenson,
Tulane Center for Cardiovascular Health, New Orleans, LA, U.S.A. |
Benefits of Tight
Glycemic Control during Coronary Revascularization
Harold L.
Lazar,
Boston Medical Center, MA, U.S.A. |
Tailoring the
Diabetic Platelet
Dominick J. Angiolillo,
University of Florida-Shands Jacksonville, FL, U.S.A. |
Impact of Metabolic
Syndrome on Myocardial Perfusion Grade after Primary Percutaneous
Coronary Intervention in Patients with Acute ST Elevation Myocardial
Infarction
Turgay Celik,
Gulhane School of Medicine, Ankara, Turkey |
GENDER
AND HEART DISEASE |
Secondary Prevention
of CHD in Women
Vera Bittner,
University of Alabama at Birmingham, AL, U.S.A. |
The Direct
Implications of Body Fat Mass and Its Topographic Distribution for
Cardiovascular Risk in Postmenopausal Women: From Risk to Protection
Laszlo B.
Tanko,
Center for Clinical and Basic Research,
Ballerup, Denmark |
Sex, Age and
Regional Differences of L-Type Calcium Channels in the Heart
Guy Salama,
University of Pittsburgh, PA, U.S.A. |
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES |
Alcohol and
Cardiovascular Diseases: 2007 Update
Arthur L.
Klatsky,
Kaiser Permanente Medical Center, Oakland, CA, U.S.A. |
Peripartum
Cardiomyopathy in the US: Definition, Clinical Presentation and
Potential Mechanisms
Uri Elkayam,
LAC and USC Medical Center, Los Angeles, CA, U.S.A.,
|
What are the New
Cancer Therapeutics Doing to the Heart?
Thomas Force,
Jefferson Medical College, Philadelphia, PA, U.S.A |
New Interventions in
the Treatment of Cardiomyopathy Related to Iron-Overload
Peter H.
Backx,
University of Toronto, Ontario, Canada |
Obesity and
Congestive Heart Failure
Martin A.
Alpert,
St. John's Mercy Medical Center, St. Louis, MO U.S.A. |
Viral Induced
Cardiomyopathy - Diagnosis and Therapy
Heinz-Peter
Schultheiss,
University Hospital Benjamin Franklin, Berlin, Germany |
Mechanisms of
HIV-Associated Cardiovascular Disease
Changyi Chen,
Baylor College of Medicine, Houston, TX, U.S.A. |
Role of Viral
Infection and Some Inflammatory Cytokines in the Development of Dilated
Cardiomyopathy
Nodar N.
Kipshidze,
Institute of Experimental and Clinical Therapy,
Tbilisi,
Rep. of Georgia |
Myocardial
Structural Changes in Long-Term Human Severe Sepsis / Septic Shock May
Responsible for Cardiac Dysfunction
Marcos A.
Rossi,
University of Sao Paulo, Ribeirao Preto, S.P. Brazil |
Coronary
Microvascular Dysfunction and Heart Failure: Which Link?
Danilo Neglia,
CNR Institute of Clinical Physiology,
Pisa,
Italy |
DIASTOLIC HEART FAILURE |
Role of Collagen Matrix in the Transition from Hypertrophy to Failure in
Hypertension
Javier Diez,
University Clinic, Pamplona, Spain |
Regression of Left
Ventricular Hypertrophy and Outcomes
Jonathan N.
Bella,
Bronx-Lebanon Hospital Center, Bronx, NY, U.S.A. |
Diastolic
Dysfunction - How to Diagnose, How to Treat
Otto M. Hess,
Inselspital, Bern, Switzerland
|
Role of Digoxin in
Diastolic Heart Failure
Ali Ahmed,
University of Alabama at Birmingham, AL, U.S.A. |
Role of
Phospholipase C Isozymes in Hypertrophy of the Adult Heart
Paramjit S.
Tappia,
St. Boniface Hospital Research Centre,
Winnipeg, Manitoba,
Canada |
VENTRICULAR REMODELING AND HEART FAILURE THERAPY |
Metabolic Therapy
for the Treatment of Heart Failure
Giuseppe M.C.
Rosano,
IRCCS San Raffaele, Roma, Italy
|
Risk Assessment in
Heart Failure
Javed Butler,
Vanderbilt University Medical Center, Nashville, TN, U.S.A. |
The Role of TGF-Beta
Signaling in Healing Myocardial Infarcts - Mechanistic Concepts and
Clinical Implications
Nikolaos
Frangogiannis,
Baylor College of Medicine, Houston, TX, U.S.A. |
The (Pro)Renin
Receptor: A New Addition to the Renin-Angiotensin System?
Alexander
H.J. Danser,
Erasmus Medical Center, Rotterdam, The Netherlands |
Chemokines in
Cardiovascular Remodeling
Christian
Weber,
Universitatsklinikum Aachen, Germany |
Remodeling of the
Vasculature in Hypertension: Relation to the Natural History
Ernesto L.
Schiffrin,
Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada |
MATRIX
MODULATION IN HEART FAILURE |
Differential Matrix Metalloproteinase Proteomic Profiling in Patients at
Risk for Heart Failure: Diagnostic and Prognostic Implications
Francis G.
Spinale,
Medical University of South Carolina, Charleston, SC,
U.S.A. |
Cardiac Dyssynchrony
Induced Inflammation And Extracellular Matrix Degradation
Francisco J.
Villarreal,
UCSD, La Jolla,
CA,
U.S.A. |
Mitochondrial
Mechanism of Metalloproteinase Activation in Congestive Heart Failure
Suresh C.
Tyagi,
University
of Louisville School of Medicine, Louisville, KY, U.S.A. |
Pleiotropic Effects
of Therapeutic Cardiac Drugs and Interventions on the Extracellular
Collagen Matrix: The Good, The Bad and The Ugly
Bodh
I. Jugdutt,
University of Alberta Hospitals, Edmonton, Alberta, Canada |
CARDIOPROTECTION |
Beneficial Effects
of A 5-HT2A Receptor Antagonist in Congestive Heart Failure
Naranjan S.
Dhalla,
St. Boniface Hospital Research Centre,
Winnipeg, Manitoba,
Canada |
Protein Kinase C And
Heart Disease - from Cardiac Ischemia to Heart
Failure
Daria Mochly-Rosen,
Stanford University School of Medicine, CA,
U.S.A. |
Cardioprotective
Actions of Adiponectin
Noriyuki
Ouchi,
Boston
University School of Medicine, MA, USA
|
The No-Reflow
Phenomenon: Diagnosis and Treatment
Leonarda
Galiuto,
Catholic University of the Sacred Heart, Rome, Italy |
BIOMARKERS IN
HEART FAILURE |
Serial Biomarkers in
Chronic Heart Failure: What Happens over Time
Wayne Miller,
Mayo Clinic, Rochester, MN, U.S.A. |
Can NT-PROBNP Levels
Help Prevent Cardiovascular Events?
Duncan J.
Campbell,
St. Vincent's Institute of Medical Research, Fitzroy, Victoria,
Australia |
PRO-BNP Diagnostic
Consideration of Dyspnea in Patients with COPD and/or Left Ventricular
Failure
Nestor J. Angomachalelis,
Aristotle
University School of Medicine, Thessaloniki, Macedonia, Greece
|
Heat Shock Protein
60 in Heart Failure: Friend or Foe?
Anne A. Knowlton,
University
of California, Davis, CA, U.S.A. |
Natriuretic Peptides
in the Approach to HF Patients
Paulo M. Bettencourt,
Hospital S Joao, Porto, Portugal |
DRUG TREATMENT
FOR HEART FAILURE: NEW APPROACHES |
Aquaretic Agents for
Heart Failure
Robert E. Hobbs,
The Cleveland Clinic Foundation, OH, U.S.A. |
The Kidney in Heart
Failure: A Therapeutic
Target
John C.
Burnett,
Mayo Clinic and Foundation, Rochester, MN, U.S.A. |
Inotropes in
Advanced Heart Failure. A Minority Opinion
John N. Nanas,
University of Athens, Greece
|
Changing Paradigms
of Cardiovascular Interventions
Hanumanth K. Reddy,
University of Missouri-Columbia, U.S.A. |
Cardiovascular
Disease in Renal Failure: What's New?
Rene R.
Wenzel,
Cardiology & Nephrology-Cardiovascular Research, Zell am
See,
Austria |
The Impact of Beta
Blockers on Central Sleep Apnea in Chronic Heart Failure
Akira Tamura,
Oita University, Japan |
Beta-Blockers and
Cardiopulmonary Variables in CHF
Klaus K.
Witte,
Leeds General Infirmary and University of Hull, UK |
Metabolic Modulation
in Heart Failure: Diabetes and Beyond
W.H. Wilson
Tang,
Cleveland Clinic Foundation, OH, U.S.A. |
DEVICES AND
SURGICAL THERAPIES FOR HEART FAILURE |
Patient Selection of
Left Ventricular Assist Device Implantation - Endlessly Moving Target
Yoshifumi
Naka,
College of Physicians and Surgeons, New York, NY, U.S.A. |
Passive Restraining
Devices
Randall C.
Starling,
Cleveland Clinic Foundation, Cleveland, OH, U.S.A. |
Baroreflex
Activation Therapy for the Treatment of Heart Failure
Hani N.
Sabbah,
Henry Ford Heart & Vascular Institute,
Detroit,
MI,
U.S.A. |
Implanted
Hemodynamic Monitoring in the Therapy of Heart Failure
Robert C.
Bourge,
The University of Alabama, Birmingham, AL, U.S.A. |
The Selection of
Patients with Heart Failure who Benefit from Cardiac Resynchronization
Therapy
Maria
Vittoria Pitzalis,
East Carolina University, Greenville, NC, U.S.A.
|
Percutaneous Left
Ventricular Support in the Catheterization Laboratory and Beyond. What
can we expect in the Nearby Future?
Jose P.S.
Henriques,
Academic Medical Center, Amsterdam, The Netherlands
|
Heart
Retransplantation - Is it a Viable Option and if so, When?
Maryl R.
Johnson,
University of Wisconsin-Madison, WI, U.S.A |
Pediatric Mechanical
Circulatory Support: New Devices and Latest Developments
Brian W.
Duncan,
The Children's Hospital at the Cleveland Clinic, OH, U.S.A. |
Surgical Options for
End-Stage Heart Failure
Roland Hetzer,
German Heart Institute, Berlin, Germany |
PERICARDIAL
DISEASES |
Leading Issues and
Controversies in Pericardial Disease
David H. Spodick,
University of Massachusetts Medical School, Worcester, MA, U.S.A. |
Acute and Recurrent
Pericarditis
Massimo Imazio,
Maria Vittoria Hospital, Torino, Italy |
RISK
STRATIFICATION FOR SUDDEN CARDIAC DEATH |
Fluctuations of ECG
and Risk Stratification in Brugada Syndrome
Masahiko J.
Takagi,
Osaka City University Graduate School of Medicine, Japan |
Update on Management
of Right Ventricular Outflow Tract Tachycardia
Rungroj
Krittayaphong,
Siriraj Hospital, Bangkok, Thailand |
Population-Based
Analysis of Sudden Cardiac Death: Clinical Implications
Sumeet S. Chugh,
Oregon
Health and Science University, Portland, OR, U.S.A. |
How Best to Identify
Patients at Risk for Sudden Cardiac Death
Michael E. Cain,
Washington University School of Medicine, St. Louis, MO, U.S.A. |
Current Perspectives
in Risk Stratification for Sudden Cardiac Death
Dan Wichterle,
Institute for Clinical and Experimental Medicine,
Prague,
Czech Republic |
Sudden Cardiac Death
in Young Individuals: Clinical and Genetic Investigation of the Family
Pascal McKeown,
Queen's University Belfast, Ireland |
Risk Stratification
for Sudden Cardiac Death: Where are we now, where do we need to be?
Sana M. Al-Khatib,
Duke Clinical Research Institute, Durham, NC, U.S.A. |
ADVANCES IN
THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS |
Is it Possible to
Reduce Hospitalization Costs for Patients Considered at Risk of Serious
Arrhythmias?
Antonio
Martinez-Rubio,
Hosp. de Sabadell -Cardiology, Barcelona, Spain |
Catheter Ablation of
Ventricular Tachycardia Occurring Late After Myocardial Infarction using
Substrate Modification
Thomas Deneke,
University of Bochum, Germany
|
Rationales, Methods
and Preliminary Results of Subcutaneous Only ICDs
Riccardo Cappato,
Policlinico San Donato, Milan, Italy
|
ICD Therapy in
Patients with Arrhythmogenic Right Ventricular Cardiomyopathy
Firat Duru,
University Hospital of Zurich, Switzerland |
NEW DIAGNOSTIC
AND THERAPEUTIC APPROACHES IN ATRIAL FIBRILLATION |
Spectral Analysis of
AF Electrograms and ECGs
Andreas Bollmann,
Good Samaritan Hospital, Los Angeles, CA, U.S.A. |
Implantable Devices
in the Management of Patients with Atrial Fibrillation
Carsten W. Israel,
J.W. Goethe University, Frankfurt, Germany
|
ABLATION FOR
ATRIAL FIBRILLATION AND SVT |
Emerging Techniques
for Ablation of Atrial Fibrillation
Andrea Natale,
The
Cleveland Clinic,
Cleveland, OH, U.S.A. |
Atrial Fibrillation
and Heart Failure: Role of AVN Ablation and Pacemaker Therapy
Win-Kuang Shen,
Mayo Clinic,
Rochester, MN, U.S.A. |
Role of Real-Time
Imaging in Ablation of Atrial Fibrillation: Introducing New Imaging
Modality
Nasir F.
Marrouche,
University of Utah, Health Sciences Center, Salt Lake City UT, USA
|
Catheter Ablation of
Atrial Fibrillation
Shih-Ann Chen,
Veterans General Hospital, Taipei, Taiwan |
Determinants of
Lesion Size during Catheter Cryoablation
Mark A. Wood,
Virginia Commonwealth University, Richmond, VA, U.S.A. |
HEART FAILURE,
ARRHYTHMIAS, AND DEVICES |
CHF and AF: Who is
Guilty
Alessandro
Capucci,
Ospedale ""Guglielmo da Saliceto",
Piacenza,
Italy |
Reproducibility of
T-Wave Alternans In Patients With CHF
John E. Madias,
Elmhurst
Hospital Center, Elmhurst, NY, U.S.A. |
CRT In Patients who
do not Conform to the Official Guidelines
I Eli Ovsyshcher,
Ben Gurion University, Beer-Sheva, Israel |
Management and
Evaluation of Heart Failure after Cardiac Resynchronization Therapy
Juan M. Aranda,
Jr.,
University of Florida
College of Medicine, Gainesville, FL, U.S.A. |
ADVANCES IN
CONGENITAL HEART DISEASE |
Sudden Death and
Exercise in Patients with Native or Surgical Corrected Chd (Congenital
Heart Disease)
Luciano Daliento,
University of Padua, Padova, Italy |
Outcomes in Adult
Congenital Heart Disease
Geoffrey
Rosenthal,
The Children's Hospital at the Cleveland Clinic, Cleveland, OH, U.S.A.
|
New Perspectives in
MRI in Congenital Heart Disease
Titus Kuehne,
Department of Congenital
Heart Disease, Berlin,
Germany |
Arrhythmias in Adult
Congenital Heart Disease
Louise Harris,
University Health Network, Toronto ON, Canada |
Three-Dimensional CT
Scanning: A Routine Comprehensive Diagnostic Tool for Congenital Heart
Disease
Phalla Ou,
Hopital Necker-Enfants Malades,
Paris, France |
VALVULAR HEART
DISEASE / HEART VALVE SURGERY / DISEASES OF THE THORACIC AORTA |
How Does Acute
Aortic Dissection Pick a Time to Occur?
John A.
Elefteriades,
Yale
University School of Medicine, New Haven, CT, U.S.A. |
Therapeutic Strategy
of Acute Aortic Intramural Hematoma
Shuichiro Kaji,
Kobe General Hospital, Kobe, Japan |
Medical Therapy for
Valvular Diseases - Is it Hope or Reality?
Jeffrey S. Borer,
The New York Hospital, Cornell Medical Center,New York, NY, U.S.A. |
New Insights into
the Diagnosis and Treatment of Aortic Stenosis
Philippe Pibarot,
Hospital Laval Research Center, Sainte-Foy, Quebec,
Canada |
Bicuspid Aortic
Valve: Valvular and Vascular Implications
Pompilio Faggiano,
Spedali Civili, Brescia, Italy |
Phen-Fen
Valvulopathy 10 Years Later: What Have We Learned?
Neil J. Weissman,
Washington Hospital Center, Washington, DC, U.S.A. |
Ischemic Mitral
Regurgitation Treated with External Counterpulsation
Yzhar Charuzi,
UCLA School of Medicine, Los Angeles, CA, U.S.A. |
Possibilities and
Limitations of Aortic Valve Reconstruction
Hans-Joachim
Schafer,
University Hospital Homburg, Homburg, Germany |
Where Do We Stand
with the Stentless Aortic Valves?
Francois Dagenais,
Laval Hospital, Sainte-Foy, Quebec, Canada |
EMERGING ROLE OF PERCUTANEOUS VALVE REPAIR AND REPLACEMENT |
Transcatheter Valve
Replacement and Repair
John G. Webb,
St. Paul's
Hospital, Vancouver, B.C. Canada |
Percutaneous Mitral
Valve Repair: Concept to Reality
Saibal Kar,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |